Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
AFP (25–305)
AviHis加载中…
加载中…
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
100 μg
Protein structure
100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| AFP | AFP-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&AFP (FMNKFIYEI) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg | AFP (25–305) AviHis |
| AFP | AFP-HP005 | Human | HEK293 | Human HLA-A*02:01&B2M&AFP (PLFQVPEPV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg | AFP (25–305) AviHis |
| HLA-A*26:01 | HLAA2601-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*26:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*26:01 (25–305) AviHis |
| KRAS G12V | KRASG12V-HB004 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| HLA-C*07:02 | HLAC0702-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-C*07:02&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-C*07:02 (25–366) AviHis |
| PRAME | PRAME-HP006 | Human | HEK293 | PRAME (25–305) AviHis | |
| MAGE-A1 | MAGEA1-HP004 | Human | HEK293 | MAGE-A1 (25–305) AviHis | |
| NY-ESO-1 | NYESO1-HP008 | Human | HEK293 | Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–305) AviHis |
| HLA-A*11:01 | HLAA1101-HP003 | Human | HEK293 | Human HLA-A*11:01&B2M&RASL11B (AVVGASGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*11:01 (25–305) AviHis |
| P53 R175H | P53R175H-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | P53 R175H (25–305) AviHis |
| KRAS G12R | KRASG12R-HP002 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12R (25–305) AviHis |
| KRAS G12D | KRASG12D-HP006 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| LILRB1 | LILRB1-HP002 | Human | HEK293 | Human LILRB1/CD85j/ILT2 Protein Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB1 (116–461) His |
| Survivin 2B | SURVIVIN2B-HB001 | Human | HEK293 | Biotinylated Human HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | Survivin 2B (25–305) AviHis |
| HLA-E*01:03 | HLAE0103-HP001 | Human | HEK293 | Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| KRAS G12V | KRASG12V-HP004 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| KRAS WT | KRASWT-HB002 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | KRAS WT (25–305) AviHis |
| KRAS G12C | KRASG12C-HP005 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Tetramer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | KRAS G12C (25–305) AviHis |
| HPV16 E6 | HPV16E6-HP001 | Human | HEK293 | Human HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E6 (25–305) AviHis |
| HPV16 E7 | HPV16E7-HP001 | Human | HEK293 | Human HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E7 (25–305) AviHis |